跳至主要内容
临床试验/ITMCTR2000003540
ITMCTR2000003540尚未招募1 期

Study on metabonomic regularity of type 2 diabetes mellitus complicated with community-acquired pneumonia and its intervention by Traditional Chinese medicine.

Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • Inclusion criteria for T2DM-CAP group
  • 1. Participants have a history of type 2 diabetes and are hospitalized with confirmed CAP.
  • 2. Participants meet the criteria for pulmonary-splenic asthenia and accumulation of phlegm-dampness syndrome in TCM.
  • 3. Participants Participants aged 18–70 years, no gender limitations.
  • 4. Participants can complete this study and all tests.
  • 5. Participants provide informed written consent and volunteer to participate in the trial.
  • Inclusion criteria for T2DM group:
  • 1. Patients who meet the diagnostic criteria of diabetes, that is, the fasting blood glucose level is greater than or equal to 7.0 mmol / L, and the postprandial blood glucose is greater than or equal to 11.1 mmol / L.
  • 2. Participants Participants aged 18–70 years, no gender limitations.
  • 3. Participants provide informed written consent and volunteer to participate in the trial.
  • Inclusion criteria for CAP group
  • 1. Patients who meet the diagnostic criteria of CAP.
  • 2. Participants Participants aged 18–70 years, no gender limitations.
  • 3. Participants provide informed written consent and volunteer to participate in the trial.

排除标准

  • Exclusion criteria for T2DM-CAP group
  • 1. Patients with other coexistent pulmonary diseases (e.g., bronchiectasis,pulmonary edema, chronic obstructive pulmonary disease, tuberculosis, or interstitial lung disease).
  • 2. Patients with severe comorbidities, such as malignant tumors, infectious diseases, coronary heart disease, mental abnormality or patients whose laboratory data indicating severe systemic disease (such as liver and kidney dysfunction).
  • 3. Patients complicated with other infectious diseases;
  • 4. Women who are breastfeeding, or pregnant.
  • 5. Allergies for experimental drugs or Chinese herbal medicine.
  • 6. Patients have participated in other clinical trials in the one month preceding the trial.
  • Exclusion criteria for T2DM group
  • 1. Combined with CAP, tuberculosis and other infectious diseases;
  • 2. Patients with severe comorbidities, such as malignant tumors, infectious diseases, coronary heart disease, mental abnormality or patients whose laboratory data indicating severe systemic disease (such as liver and kidney dysfunction).
  • 3. Women who are breastfeeding, or pregnant.
  • 4. Patients with acute metabolic disorders such as diabetic ketoacidosis in the past month.
  • Exclusion criteria for CAP group
  • 1. Ccomplicated with other lung diseases (COPD, pulmonary tuberculosis, bronchial asthma, etc.).
  • 2. Complicated with diabetes.
  • 3. patients with severe complications, such as malignant tumors, infectious diseases, coronary heart disease, mental disorders or laboratory data show severe systemic diseases (such as hepatorenal dysfunction).
  • 4. Women who are breastfeeding, or pregnant.
  • 5. Complicated with other infectious diseases.

研究者

发起方
Hospital of Chengdu University of Traditional Chinese Medicine

相似试验